FDA warns about fake Avastin again
WASHINGTONThe Food and Drug Administration is warning doctors about another counterfeit version of the cancer drug Avastin distributed in the U.S., the third case involving the best-selling Roche drug in the past year.
The FDA said in an online post that at least one batch of the drug distributed by a New York distributor does not contain the active ingredient in real Avastin, which is used to treat cancers of the colon, lung, kidney and brain. The drug was distributed by Medical Device King, which also does business as Pharmalogical. The vials are packaged as Altuzan, the Turkish version of Avastin that is not approved for use in the U.S.
- Following the trail of fake Avastin
- Fake Avastin shipper tied to Canadadrugs.com
- How fake Avastin from overseas ends up in U.S.
The agency warned doctors last April about a similar case of fake Turkish Avastin distributed by a U.K. distributor.
Popular in Health
- Flesh-eating disease victim gets bionic hands
- Shocking study: Math skills improved by electric stimulus
- Skin cancer self-exam: What to look for (PHOTOS)
- Handbags may contain more germs than average toilet flush
- Depression may double stroke risk for middle-aged women
- Doctor: Gel manicures a potential skin cancer risk
- Human stem cells cloned without using fertilized egg
- Smoking marijuana linked to lower diabetes risk in study